Abstract Increased numbers of apoptotic neutrophils are found in SLE, related to disease activity and levels of anti-dsDNA antibody. The mechanism of increased apoptosis is not clear, but anti-dsDNA antibody has been shown to induce apoptosis in neutrophils from normal subjects and in certain cell lines. In this study, polyclonal anti-dsDNA antibody was isolated from the serum of a patient with active SLE, and was shown to substantially accelerate apoptosis in neutrophils from SLE patients as compared with neutrophils from healthy control or rheumatoid arthritis subjects.
Introduction
Serum anti-dsDNA antibodies are part of the classiWcation criteria for SLE [1] , and a signiWcant rise in their concentration is associated with Xare-ups of the disease, especially renal lupus [2] . Increased numbers of apoptotic neutrophils have been described in SLE, associated with Xares of disease activity and concentration of anti-dsDNA antibody [3] . There is evidence for both abnormal clearance mechanisms of apoptotic cells in SLE [4] , and increased rates of neutrophil apoptosis; our group has recently reported abnormal responses in lupus neutrophils to apoptotic control by several cytokines, including G-CSF, GM-CSF and TNF [5] . It has been suggested that monoclonal antidsDNA antibody accelerates apoptosis in neutrophils from healthy control subjects [6] , and other workers have reported increased rates of apoptosis in a range of cell lines cultured with polyclonal anti-dsDNA antibody isolated from the serum of SLE patients [7] . Taken together, these Wndings provide grounds for the hypothesis that anti-dsDNA antibody might accelerate apoptosis in SLE neutrophils, leading to failure of adequate clearance of apoptotic material and the development of autoantibodies, and thus a positive feedback loop of autoimmunity and Xare of disease activity.
Materials and methods

ImmunoaYnity chromatography
Anti-dsDNA antibodies were extracted from the serum of a lupus patient by immunoaYnity chromatography [8] . BrieXy, serum was diluted with 20 mM sodium phosphate buVer, pH 7.0, and pumped through a column packed with a proprietary recombinant Protein G with the albumin binding-site removed (HiTrap Protein G, Amersham Biosciences, Little Chalfont, UK), to which the immunoglobulin fraction of the serum becomes Wxed. Low pH buVer (0.1 M glycine-HCl, pH 2.7) was then pumped through the matrix to elute the bound immunoglobulin, and fractions of the elutant were collected, neutralized and the absorbance at 280 nm measured. Fractions containing a high concentration of the eluted immunoglobulin were pooled, and pumped through a column packed with dsDNA-cellulose (Sigma-Aldrich Co. Ltd, Poole, UK). The same low pH buVer was used to elute the bound anti-dsDNA immunoglobulins, and fractions were again collected, neutralized and the absorbance at 280 nm measured. The peak of eluted antibody was identiWed ( Fig. 1) and the anti-dsDNA antibody activity was measured by radioimmunoassay, before and after concentration of the sample in an ultraWltration cell with YM-10 membrane (Millipore, Watford, UK). Protein concentration before and after concentration was measured by the biocinchoninic acid (BCA) method [9] . Gel electrophoresis in 7.5% polyacrylamide gels was performed on samples of serum, the immunoglobulin fraction and the anti-dsDNA antibody fraction (Fig. 2) . The anti-dsDNA antibody sample was stored at ¡20°C until required for culture experiments.
Neutrophil isolation
Seven subjects fulWlling the revised ARA criteria for SLE [1] , three fulWlling the ACR classiWcation criteria for rheumatoid arthritis [10] and three healthy control subjects were recruited and gave informed consent to participation in the experiment. Blood samples were obtained, and neutrophils isolated by protein gradient centrifugation, using a technique previously described by our group [5] . In summary, plasma was removed by centrifugation and aspiration, and the cell layer mixed with a 6% solution of dextran (DextranT500, Pharmacia Biotech, UK). After standing, the leucocyte layer was aspirated, washed and resuspended in a 55% suspension of the colloid Percoll (Pharmacia Biotech, UK). A protein gradient was then prepared by layering 70% Percoll on 81% Percoll, and layering the 55% suspension on top, before centrifugation and aspiration of the neutrophil layer, which lies at the 70-81% interface. Neutrophils were washed, counted and a suspension of 1 £ 10 6 neutrophils/ml of supplemented RPMI prepared.
Cell culture
Neutrophil stock solution (0.5 ml) for each subject was aspirated immediately after isolation, and incubated with annexin V-FITC before Xow cytometry, to obtain a value for percentage of apoptotic neutrophils at T = 0, as described previously by our group [5] .
Stock solutions of anti-dsDNA antibody of concentration 1 £ 10 ¡3 to 1 £ 10 3 ng/ml were then prepared with sterile water. Cultures were prepared in a standard multi-well plate with 1 ml (1 £ 10 6 neutrophils) in each well, to which was added an appropriate quantity of the stock solution of anti-dsDNA antibody to produce concentrations of 0.01, 0.1, 1, 10, 100 and 1,000 ng/ml, respectively, of anti-dsDNA antibody. Control wells were also prepared without anti-dsDNA antibody.
The plate was cultured in a 5% CO 2 atmosphere at 37°C, and 0.5 ml of each culture aspirated at 2 h (T = 2) and 24 h (T = 24) for annexin V-FITC incubation and Xow cytometric analysis as before.
Results
The results of the radioimmunoassay performed on the serum, immunoglobulin, and dsDNA antibody fractions are shown in Table 1 . The change in concentrations between successive samples reXected the dilution of fractions with running buVer as well as any loss of protein during the isolation process. The eVect of addition of anti-dsDNA antibody to the culture was expressed as a positive or negative percentage of the proportion of apoptotic neutrophils determined after 2 or 24 h without antibody.
The median values for the percentage of apoptotic neutrophils in each sample at 2 h is shown in Fig. 3 . Although the small sample numbers preclude statistical analysis, it is clear that the addition of anti-dsDNA antibody had minimal eVect on apoptosis of RA or control neutrophils, while there is a substantial increase in the proportion of apoptotic neutrophils in samples from SLE subjects. This was seen at all concentrations of anti-dsDNA antibody.
Culture for 24 h had negligible eVect on the proportion of apoptotic neutrophils in any of the three subject groups (Fig. 4) .
Although sample sizes were very small, there was no obvious trend in the response to culture with antidsDNA antibody and any marker of disease activity in either the SLE or RA subjects.
Discussion
In this pilot study, isolation of anti-dsDNA antibody from the serum of a SLE patient was conWrmed by the measurement of antibody activity by radioimmunoassay, and culture of neutrophils with this fraction appeared to inXuence the rate of apoptosis in the cells. A trend towards increased numbers of apoptotic neutrophils is noted in lupus neutrophils compared with RA or healthy controls.
The Wnding of increased apoptosis in neutrophils cultured with anti-dsDNA antibody is in line with published studies, using a monoclonal antibody and healthy control neutrophils [6] , or anti-dsDNA antibody isolated from the sera of SLE patients, showing increased annexin V binding (apoptosis) in permanent cell lines [7] . In this last study, greater sensitivity was described in some cell lines (eg. L929) to apoptosis induction by anti-dsDNA antibody than others (eg. HL-60, Raji). This group found up to sevenfold increases in the percentage of apoptotic cells after 48 h cultures with anti-dsDNA antibody. It is diYcult to compare these Wndings with our own, as cells were cultured for twice as long, and the cell lines used were more resistant to constitutive apoptosis than human neutrophils. However, the potential for diVerential apoptotic responses of cell lineages to culture with anti-dsDNA antibody is nevertheless demonstrated.
A weakness of this study is the inability to demonstrate conclusively that the fraction of serum which we have called 'anti-dsDNA antibody' in fact contains only anti-dsDNA antibody, and that it is not other constituents of the preparation which are creating the observed eVect, or interfering with the full eVect of the anti-dsDNA antibody. Gel electrophoresis shows that the preparation contains a high percentage of immunoglobulin, and radioimmunoassay conWrms anti-DNAse activity. Nevertheless, it is possible that some other related antibodies, such anti-ssDNA or anti-nucleosome antibody might become adherent to the dsDNA matrix, be eluted by the acid buVer and so be included Concentration of anti-dsDNA antibody (/ml) % change from culture without antibody Control SLE RA in the Wnal stock solution used for culture. While this may reXect the milieu in which apoptosis of neutrophils occurs in vivo, oVering an advantage over experiments using recombinant monoclonal anti-dsDNA antibody, it does allow for the possibility that some of the observed eVect is caused by antibodies other than antidsDNA antibody. Extraction of anti-ssDNA or antinucleosome antibodies from the same serum using similar protein columns, and subsequent culture experiments using these fractions might be required to clarify the observations. Levels of these other antibodies could also be estimated in the Wnal samples by ELISA. A larger study could also involve the culturing of neutrophils with anti-dsDNA antibody produced from a range of diVerent SLE subjects.
Conclusion
Activity of anti-dsDNA antibody was demonstrated in a fraction isolated from the serum of a SLE patient, and caused increased numbers of apoptotic neutrophils when cultured with neutrophils from SLE subjects as compared with RA or healthy control subjects. A larger study is indicated to conWrm these Wndings and further investigate the mechanisms involved. These Wndings are consistent with the hypothesis that excessive numbers of circulating apoptotic cells in SLE are explained by the eVect of exposure to anti-dsDNA antibodies, and suggest that lupus cells are particularly sensitive to such exposure.
